Structural Determinants of Conformationally Selective, Prion-binding Aptamers[boxs]

We have recently described the isolation of 2′-fluoropyrimidine-substituted RNA aptamers that bind selectively to disease-associated β-sheet-rich forms of the prion protein, PrP, from a number of mammalian species. These aptamers inhibit the accumulation of protease-resistant forms of PrP in a prion-seeded, in vitro conversion assay. Here we identify the minimal portions of two of these aptamers that retain binding specificity. We determine their secondary structures by a combination of modeling and solution probing. Finally, we identify an internal site for biotinylation of a minimized, synthetic aptamer and use the resultant reagent in the detection of abnormal forms of PrP in vitro.